Tech Company Financing Transactions

Charm Therapeutics Funding Round

Charm Therapeutics, operating out of London England, scored $80 million from New Enterprise Associates, SR One Capital Management and F-Prime Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

7 Pancras Sq
London England, N1C 4AG
UK

Phone

Undisclosed

Website

www.charmtx.com

Email Address

[email protected]

Overview

Founded by leaders with a track record in next-wave AI, with a culture of excellence and innovation at its heart and a commitment to delivery. We are an entrepreneurial team of extraordinary scientists, engineers and entrepreneurs, purpose-built to meld cutting edge know-how from 3D deep learning and drug discovery.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Laksh Aithani

        

Co-Founder

David Baker

        

Browse more venture capital transactions:

Prev: 9/2/2025: Intella venture capital transaction
Next: 9/3/2025: Sierra venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary